Amgen Inc on Wednesday said it filed with U.S. health regulators seeking approval to sell its first biosimilar drug, which would be a less expensive alternative to AbbVie's Humira, the world's top-selling prescription medicine.
(Reuters Health) - Wheelchair users may be more likely to die in collisions with cars than other pedestrians, an analysis of U.S. crash data suggests.
(Reuters Health) - Red meat – but not other types of protein - is linked to an increased stroke risk, and the odds go up the more meat people eat, a recent study suggests.
At least 19 people in seven states may have been infected by E. coli after eating rotisserie chicken salad sold at Costco Wholesale Corp's stores, the U.S. Centers for Disease Control and Prevention said on Tuesday.
(Reuters Health) - Particle pollution like soot is a known health hazard and linked to the risk of heart disease and stroke, but women with diabetes are even more vulnerable than most people, according to a new U.S. study.
(Reuters Health) - People who speak two languages are twice as likely as those who only speak one to regain normal cognitive function after a stroke, according to a new study.
(Reuters Health) - The price of many drugs prescribed by U.S. dermatologists has skyrocketed over the past six years, far exceeding increases in overall health care costs and stretching patients' budgets in an era of high insurance deductibles, according to a new study from Florida.
PARIS France, the European Union's biggest agricultural producer, reported its first outbreak of the deadly H5N1 bird flu virus in eight years after detecting it in a backyard in a southwestern region home to many foie gras and poultry producers.
A U.S. District Court on Wednesday denied specialty pharmacy Linden Care LLC's request for a temporary restraining order (TRO) against Express Scripts Holding Co for dropping it from its network earlier this month.
ZURICH The European Union gave its green light to Roche's Cotellic for use in combination with the drug Zelboraf against advanced melanoma, the company said on Wednesday.
Prosecutors demanded details from Valeant Pharmaceuticals on its patient assistance programs, drug pricing and distribution practices. Full Article